Gedea Biotech receives grant for accelerated development

Things goes well for the newly started company Gedea Biotech AB. During the first months of this year, the company, which is still in an early stage, received nearly one million crowns in grants. Now awaits continued development and then clinical studies and the company expects to be able to have…


Gedea Biotech winner of Future Innovation prize

Gedea Biotech won first prize at Lund University and Sparbanksstiftelsen Finn's competition for future innovations. The award was presented at Lund University's annual Innovation kickoff. The contest was open to all students and employees at Lund University. 77 entries were received, and a few were…


Gedea Biotech receives funding from Vinnova

Vinnova has granted Gedea Biotech's application for innovative startup companies. The applications were reviewed by external assessors and Gedea Biotech was one of the selected among over 650 applicants. Gedea Biotech develops a novel treatment of vaginal candida infections. In the project a…


LU Holding invests in new treatment for common female problems

Three-quarters of all women suffer at some time of fungal infections in the genital area, which gives physical discomfort in the short term but is also likely to cause chronic problems. Now a research team at Lund University have found a naturally occurring substance, which in test tube studies…


Gedea Biotech AB
Medicon Village
Scheeletorget 1
223 81 Lund
Sweden

Annette Säfholm, CEO
annette.safholm@gedeabiotech.com
+46 (0) 708 – 91 86 81